[18F]PI-2620 Phase 3 Histopathological Study

Clinical trial NCT05641688 · RECRUITING

Trial details

NCT number: NCT05641688
Sponsor: Lantheus Biosciences Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2022-12-01
Primary completion: 2027-06-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.